Due to the dramatic increases in their prevalence, diabetes and obesity have become among the most common and costly health problems in the U.S. and other developed countries. Two-thirds of the ***** U.S. population is overweight and one-half of those individuals – one-third of the ***** population – are obese. The prevalence of type 2 diabetes has also increased markedly in recent decades not only among *****s, but in children as well. Although type 1 diabetes is less common, it is a potentially devastating disorder affecting both children and *****s and, while treatments for both types of diabetes exist, neither is curable and effective treatments for obesity are yet to be developed. Desire to find cures for diabetes, obesity and related metabolic syndrome are high pushing the demand for innovative reagents for research in this area.
Other Products for Diabetes/Obesity Research
Catalog # Product Name+ Size Price(RMB) 1653-10 Cambinol 10 mg 7776-10 Glucokinase, human liver, recombinant 10 μg 1875 7777-10 Glucokinase, human pancreatic, recombinant 10 μg 1875 1873-5 Salermide 5 mg 1425 1873-25 Salermide 25 mg 5925 1652-10 SIRT1 Inhibitor, EX-527 10 mg 2325 1651-10 SIRT2 Inhibitor, AGK2 10 mg 2325 1874-50 Suramin Hexasodium Salt 50 mg 975 1874-250 Suramin Hexasodium Salt 250 mg 3900
**Other Products for Diabetes/Obesity Research*Other Products for Diabetes/Obesity Research**Other Products for Diabetes/Obesity Research*Other Products for Diabetes/Obesity Research**
沪公网安备 31011502007621号
